Abiopharma

🔍 Varrier Rajesh (Executive)

Company: COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 749 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,072.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 272 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,344.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Acquired 250 shares of Class A Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,594.00 | transaction_form_type: 4 | Footnotes: F4, F2
• Sold 466 shares of Class A Common Stock at $52.17 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,128.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 749 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 749.00 | transaction_form_type: 4 | Footnotes: F2, F6, F6
• Sold 272 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 816.00 | transaction_form_type: 4 | Footnotes: F2, F7, F7
• Sold 250 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,746.00 | transaction_form_type: 4 | Footnotes: F2, F8, F8

Footnotes:

• F1: Shares of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company") received from the vesting of 1/8th of the restricted stock unit ("RSU") award granted on September 3, 2024.
• F2: Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock.
• F3: Shares of Class A Common Stock of the Company received from the vesting of 1/3rd of 1/6th of the RSU award granted on September 3, 2024.
• F4: Shares of Class A Common Stock of the Company received from the vesting of 1/12th of the RSU award granted on March 3, 2025.
• F5: Shares of the Company's Class A Common Stock withheld to pay applicable taxes.
• F6: A total of 5,991 RSUs were originally granted on September 3, 2024 under the Company's 2023 Incentive Award Plan and such originally granted amount began vesting in quarterly installments over two years, commencing on December 15, 2024, with 1/8th of such RSUs vesting on each quarterly vesting date so that such RSUs will be fully vested on the eighth quarterly vesting date (September 15, 2026).
• F7: A total of 4,884 RSUs were originally granted on September 3, 2024 under the Company's 2023 Incentive Award Plan and such originally granted amount began vesting in 10 successive quarterly installments, commencing on December 15, 2024, with (i) 1/6th of such RSUs vesting on each of the first two vesting dates; (ii) 2/3rds of 1/6th of such RSUs vesting on each of the successive four vesting dates; (iii) 1/3rd of 1/6th of such RSUs vesting on each of the successive three vesting dates; and (iv) the remainder of such RSUs vesting on the tenth vesting date (March 15, 2027).
• F8: A total of 2,993 RSUs were originally granted on March 3, 2025 under the Company's 2023 Incentive Award Plan and such originally granted amount began vesting in quarterly installments over three years, commencing on June 15, 2025, with 1/12th of such RSUs vesting on each quarterly vesting date so that such RSUs will be fully vested on the twelfth quarterly vesting date (March 15, 2028).